Recludix Pharma, a leader in the discovery of inhibitors for challenging targets in inflammatory disease, today announced a ...

Minecraft players have always used the endless possibilities of the blocky world to create something fantastic, from massive towns, cities, and even countries to complicated redstone machines such as ...

Novel RBM39 molecular glue achieves complete tumor regression in mechanism-based Ewing sarcoma models; IND filing expected ...

Findings highlight PL9654 and PL9655's potential to treat diabetic retinopathy through inflammation resolution, vascular stabilization, and neuroprotection PL9654 ...

ECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion therapies for the treatment of liver disorders with significant unmet need, today announced ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - ...

Presentations will be available on the Alterity Therapeutics website here.

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

The scene was downtown Tbilisi. The year 2005. And the 43rd President of the United States, George W. Bush proclaimed ...

Interview: ‘I am neither from Telangana, nor politically aligned; I deliver work: IAS Jayesh Ranjan- The SPEED boss ...

Imagine turning discarded aluminum printing plates into a shimmering castle in the middle of Florida swampland. That’s not ...